middle.news
Cambium Bio Unlocks US$2M+ Dental Licensing Deal with Keke Medtech
1:21pm on Tuesday 2nd of September, 2025 AEST
•
Healthcare
Read Story
Cambium Bio Unlocks US$2M+ Dental Licensing Deal with Keke Medtech
1:21pm on Tuesday 2nd of September, 2025 AEST
Key Points
Exclusive licensing agreement with Keke Medtech for dental and oral wound healing
Upfront payment of US$250,000 plus US$1.75 million in development milestones
Double-digit royalties and ongoing supply relationship secured
Keke responsible for clinical development and regulatory approvals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cambium Bio (ASX:CMB)
OPEN ARTICLE